Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma

Award Number: R01AI184623
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/09/2024
PERIOD OF PERFORMANCE END DATE: 05/31/2029

Group Awards By:

View Award Description

Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma - PROJECT SUMMARY/ABSTRACT. Novel vaccination strategies are necessary to contain the TB pandemic, as the currently licensed anti-tubercular vaccine, Bacille Calmette-Guerin (BCG), has limited and variable efficacy. Attenuated, live-replicating Mycobacterium tuberculosis (Mtb) express the full complement of protective antigens not present in BCG. As a result, these strains are most likely to induce long-lived immune responses and generate durable protection. Rhesus macaques vaccinated with an isogenic Mtb mutant in the allele encoding the stress-response master regular SigH (DsigH) were protected from TB after infection with a lethal dose of Mtb, and characterized by the presence of inducible bronchus associated lymphoid tissue (iBALT) and robust T cell responses in the lungs. Protection by DsigH could be reversed by the depletion of CD20+ B cells which ablates iBALT. Protection with DsigH was validated in cynomolgus macaques, a second NHP species used as a model for TB vaccination. Preliminary data presented in this proposal indicates that protection elicited by DsigH is based on the generation of very early, potent, innate immune responses in the lung that drive rigorous immune dynamics and interactions. We propose to use cutting-edge techniques that our group has optimized, such as single cell RNA sequencing in airways and lungs, PET/CT scans of whole animals and single cell imaging, to fully understand elite lung responses generated by DsigH compared to Mtb. Our proposed work will not only provide in-depth knowledge of immune responses generated by a potential human intervention for TB, but also identify mechanisms by which Mtb infection can be sterilized prior to the formation of the granuloma.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $1,231,164 )
2025	2025	TEXAS BIOMEDICAL RESEARCH INSTITUTE	8715 W MILITARY DR	SAN ANTONIO	TX	78227	BEXAR	USA	Allergy and Infectious Diseases Research	000	2	5/20/2025	NON-COMPETING CONTINUATION	$1,231,164
														Subtotal = $1,231,164

Issue Date FY: 2024 ( Subtotal = $1,091,124 )
2024	2024	TEXAS BIOMEDICAL RESEARCH INSTITUTE	8715 W MILITARY DR	SAN ANTONIO	TX	78227	BEXAR	USA	Allergy and Infectious Diseases Research	000	1	7/9/2024	NEW	$1,091,124
														Subtotal = $1,091,124

Grand Total All Awards = $2,322,288

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma

Award Number: R01AI184623

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/09/2024

PERIOD OF PERFORMANCE END DATE: 05/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer